Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Intézmény

Vejle Sygehus

Vejle, DániahealthcareHonlap

Más néven: Vejle Hospital

60futó vizsgálat
23lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer
NCT07903883· Forrás
Még nem toboroz
Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer
2025-522431-34-00· 2. fázis· Forrás
Még nem toboroz
Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies
NCT07878208· Forrás
Toboroz
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
NCT07648264· 3. fázis· Forrás
Még nem toboroz
Examination of Rectal Blood Supply During Rectal Cancer Surgery Using Laser Speckle Contrast Imaging
NCT07799740· Forrás
Toboroz
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245· 2. fázis· Forrás
Még nem toboroz
Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
2026-525513-31-00· 3. fázis· Forrás
Meghívásos bevonás
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
NCT06788340· 4. fázis· Forrás
Toboroz
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
NCT07218809· 3. fázis· Forrás
Toboroz
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
NCT07222800· 3. fázis· Forrás
Toboroz
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
NCT07201194· Forrás
Fut, nem toboroz
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121· 2/3. fázis· Forrás
Toboroz
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07213804· 3. fázis· Forrás
Toboroz
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262· 2. fázis· Forrás
Toboroz
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
NCT07023289· 2. fázis· Forrás
Toboroz
Prehabilitation to Patients With Prostate Cancer
NCT07162987· Forrás
Toboroz
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086· 3. fázis· Forrás
Toboroz
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099· 3. fázis· Forrás
Toboroz
Self-administration of Subcutaneous Elranatamab in the Patients' Homes.
NCT06015542· 2. fázis· Forrás
Toboroz
SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening
NCT06714318· Forrás
Fut, nem toboroz
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma
2024-512113-41-00· 3. fázis· Forrás
Toboroz
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779· 3. fázis· Forrás
Toboroz
Understanding and Tailored Treatment of Low Anterior Resection Syndrome
NCT07573371· Forrás
Toboroz
Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
NCT06505369· 2. fázis· Forrás
Fut, nem toboroz
TALTEC: A phase II study measuring MRD negativity after bispecific T-cell redirectors TALquetamab and TEClistamab consolidation as part of first line treatment in transplant eligible multiple myeloma patients
2023-508212-38-00· 2. fázis· Forrás
Toboroz
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176· 3. fázis· Forrás
Fut, nem toboroz
VIsualization of Coronary Artery Disease for Modification of RISK Factors
NCT06413641· Forrás
Fut, nem toboroz
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
NCT06191744· 3. fázis· Forrás
Toboroz
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007· 3. fázis· Forrás
Fut, nem toboroz
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
NCT05936359· 1. fázis· Forrás
Fut, nem toboroz
Phase II multicenter clinical trial: Mosunetuzumab for early relapse of follicular lymphoma in the Nordic countries (MERLIN/NLG-FL6/ML43841)
2022-500100-21-01· 2. fázis· Forrás
Toboroz
NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
NCT05572801· Forrás
Toboroz
DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
NCT06076811· Forrás
Fut, nem toboroz
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
NCT03129490· 4. fázis· Forrás
Fut, nem toboroz
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515· 3. fázis· Forrás
Fut, nem toboroz
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
NCT05624554· 3. fázis· Forrás
Toboroz
FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer
NCT05810701· Forrás
Toboroz
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
NCT05552222· 3. fázis· Forrás
Toboroz
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
NCT05444348· Forrás
Toboroz
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
NCT05404230· Forrás
Toboroz
Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients
NCT05053997· Forrás
Fut, nem toboroz
Protons vs. Photons for High-risk Prostate Cancer
NCT05350475· Forrás
Fut, nem toboroz
Shared Decision Making on Radiation Dose for Lung Malignancies
NCT04940936· Forrás
Fut, nem toboroz
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
NCT04628494· 3. fázis· Forrás
Fut, nem toboroz
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421· 3. fázis· Forrás
Toboroz
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
NCT04613596· 2/3. fázis· Forrás
Fut, nem toboroz
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541· 1/2. fázis· Forrás
Fut, nem toboroz
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
NCT04663347· 1/2. fázis· Forrás
Fut, nem toboroz
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)
NCT04497844· 3. fázis· Forrás
Toboroz
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
NCT04332822· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
A Study of Tobemstomig/RO7247669 Combined with Nab-Paclitaxel Compared with Pembrolizumab Combined with Nab-Paclitaxel in Participants with Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
2022-502457-34-00· 2. fázis· Forrás
Lezárult
Subcutaneous immunoglobulin (HyQvia) against early infections in multiple myeloma: SHIELD
2023-505053-40-00· 2. fázis· Forrás
Lezárult
MRI T1 Relaxation Time in Rectal Cancer
NCT05876026· Forrás
Lezárult
Implementation of Smoking Cessation Support During Lung Cancer Workup
NCT05192031· Forrás
Lezárult
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
NCT05071664· 2. fázis· Forrás
Lezárult
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
NCT04776148· 3. fázis· Forrás
Lezárult
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
NCT04472429· 3. fázis· Forrás
Lezárult
Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet
NCT04191616· 2. fázis· Forrás
Lezárult
Single-stapled Double Purse-string Technique for Colorectal Anastomosis
NCT04223141· Forrás
Lezárult
Registry of Asthma Patients Initiating DUPIXENT®
NCT04287621· Forrás
Lezárult
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
NCT04175470· 2. fázis· Forrás
Fut, nem toboroz
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
NCT04008030· 3. fázis· Forrás
Lezárult
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT03778931· 3. fázis· Forrás
Fut, nem toboroz
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
NCT03539744· 3. fázis· Forrás
Lezárult
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
NCT03562832· 2. fázis· Forrás
Lezárult
Prevention of Chest Pain in Chemo-treated Cancer Patients
NCT03486340· Forrás
Lezárult
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
NCT03056755· 2. fázis· Forrás
Lezárult
A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
NCT02975934· 3. fázis· Forrás
Lezárult
Quality of Life the Danish Multiple Myeloma Patients
NCT02892383· Forrás
Lezárult
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
NCT02950051· 3. fázis· Forrás
Lezárult
Shared Decision Making With Anal Cancer Patients on Radiation Dose
NCT02785263· Forrás
Lezárult
Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer
NCT02705300· 2. fázis· Forrás
Lezárult
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
NCT02003924· 3. fázis· Forrás

Vizsgálati helyszínek

Intézményadatok: ROR 00e8ar137 (CC0-1.0)Frissítve: 2026. nov. 3.

Építés alatt, nem éles – Vejle Sygehus: vizsgálatok és kutatócsoportok – Frontlight Research